Clinical trials recruiting for Refractory Systemic Lupus Erythematosus

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
  NCT07432334 · Phase: Phase 1 · Ages: 16 Years to 55 Years · Sex: All (male and female) · 1 location
• IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)
  NCT07617740 · Phase: Early Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE)
  NCT06513429 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis
  NCT06676631 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
  NCT07523542 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Refractory Systemic Lupus Erythematosus often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Refractory Systemic Lupus Erythematosus trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.